Beractant (Survanta)

Pulmonary surfactant

Beractant (Survanta)

Forms and strengths
Form: TabletStrength: 100 mg phospholipids/4 mL, 200 mg phospholipids/8 mL
Print

Indication

  • Beractant is used for prevention (prophylaxis) of respiratory distress syndrome (RDS) in premature infants at risk of developing RDS or with evidence of pulmonary immaturity.
  • Beractant is used for treatment (rescue) of RDS confirmed by chest X-ray in premature infants who require mechanical ventilation.
  • Its use has not been evaluated in infants weighing less than 600 g or more than 1750 g at birth, and there is no controlled experience combining it with experimental RDS therapies such as high-frequency ventilation or extracorporeal membrane oxygenation.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.